Shaanxi Sier Biotechnology Co., Ltd., established on 2012-04-25, Business scope includes general items:software development;Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of agricultural and sideline products;Food Internet Sales(Only sell prepackaged food);food sales(Only sell prepackaged food);Fire Equipment Sales;Sales of labor protection products;Home Appliance Sales;Sales of electronic special equipment;electronics sales;Electronic Components Retail;Chemical product sales(No licensed chemical products);Biochemical product technology research and development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices;Technology Import and Export;Import and export;Intelligent basic manufacturing equipment manufacturing;Electronic special equipment manufacturing;Cloud Computing Equipment Technical Services;Information system operation and maintenance services;Network and Information Security Software Development;internet data service;Cosmetics Retail;Cosmetics Wholesale;Health Consulting Services(Does not include medical services);Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Healthy food(prepackaged)Sales;Remote Health Management Services;Information Consulting Service(Not including licensing information consulting services);Health Care Services(non-medical);Traditional Chinese Medicine Health Care Services(non-medical);internet sales(Except for products that require a license for sale);Daily necessities sales;Sports Health Service;Data processing and storage support services;Big data service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices;Internet information service;Drug retail;Drug Wholesale;medical service;Internet culture management;Radio and television program production and management;The second type of value-added telecommunications services;Drug internet information service;Internet Information Service for Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Nanjing Daoda Pharmaceutical Co., Ltd., established on 2013-10-11, The scope of business includes two types of6826Other physical therapy and rehabilitation equipment,6864Production of other medical hygiene materials and dressings;biomedicine,Research and development of medical device products;Iclass of medical devices,disinfectant,Research and development of hygiene products,Production,Sales;Sales of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Asahi Breweries Ltd. engages in the manufacture and sale of alcoholic beverages and soft drinks. Its products include beer, whisky and spirits, wine, alcohol -taste beverages, chilled beverages such as tea-based drinks, coffee, carbonated soft drinks, water, fruits and vegetable drinks, lactic acid drinks and others. The company was founded on September 1, 1949 and is headquartered in Tokyo, Japan.

Xi'an Xianfu Biotechnology Co., Ltd., established on 2019-08-20, Business scope includes technology research and development in the field of biotechnology,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhengzhou Houyi Pharmaceutical Co. Ltd. is a Chinese private company located in Zhengzhou that manufactures veterinary drugs.

Jiangxi 3L Medical Products Group Co., Ltd., established on 1990-03-01, The scope of business includes sales of second-class medical devices,Manufacturing of medical packaging materials,Sales of new membrane materials,Retailing of protective equipment for healthcare workers,Wholesale of protective equipment for medical staff,Office Equipment Sales,Sales of office equipment consumables,Office Supplies Sales,Manufacturing of daily chemical products,Sales of daily chemical products,Machinery sales,Sales of mechanical and electrical equipment,Technology Import and Export,Import and export agency,Import and export,Sales of hygiene products and single-use medical products,Production of labor protection products,Sales of labor protection products,Wholesale medical masks,Medical Mask Retail,daily mask(non-medical)Production,daily mask(non-medical)Sales,Disinfectant sales(Free of Hazardous Chemicals),Production of Class I Medical Devices,Sales of Class I Medical Devices,Production of protective equipment for medical personnel(Ι class medical device),internet sales(Except for products that require a license for sale),Production of Class II Medical Devices,Production of Class III Medical Devices,Class III medical device business,Production of protective equipment for medical personnel(Class II medical device),Production of hygiene products and single-use medical products,Production of medical masks.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Part of Perrigo Co. Plc, Neuralab Ltd. is an Irish company. The firm prepares pharmaceutical products.

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Heilongjiang Anbijie Biotechnology Co., Ltd., established on 2015-11-02, Business scope includes biotechnology research and development;distribution:medical instruments.

Weishi Pet Nutrition Research Institute (Wuhu) Co., Ltd., established on 2021-06-28, Business scope includes licensed projects:feed production;pet keeping(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Bio-feed R&D;Agricultural Science Research and Experimental Development;Natural science research and experimental development;Medical Research and Experimental Development;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;market survey(Does not include foreign investigations);Technology intermediary service;Entrepreneurial Space Services;Intellectual Property Services;Information Technology Consulting Services;business management;Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;Pet Food and Supplies Wholesale;Pet food and supplies retail;pet service(No Animal Treatment)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Chifeng Born Pharmaceutical Co., Ltd., established on 2004-05-19, Business scope includes licensed business items:No general operating items:blood products(tetanus antitoxin),Freeze-dried powder injection(hormones),Terminally sterilized small volume injection(hormones),Sterile API(blood hormone).(Operate within the validity period of the license),Technology development in the field of biotechnology,transfer,Consulting and Services;processing services;road transportation;import and export trade.

Healthbanks Biotech Co., Ltd. is a Taiwanese private company located in Taipei. The firm manufactures pharmaceutical products.

Resistentia Pharmaceutical's business strategy is to develop and commercialize immunotherapy as a second generation therapy to monoclonal antibodies for the treatment of chronic diseases.\nResistentia’s most advanced program is an immunotherapy against allergy/asthma – a growing health problem with a large unmet medical need. In contrast to existing therapies, which are largely symptomatic, Resistentia’s novel immunotherapeutic approach targets the cause of the allergic reactions, rather than the symptoms.\nIn addition, Resistentia is developing an immunotherapy for the treatment of rheumatoid arthritis. The project is currently in discovery phase.

Adeka Corp. engages in the manufacture and sale of chemical and food products. Its operations are carried out through the following segments: Chemical Products, Food Products, Life Science and Others. The Chemical Products segment produces semiconductor materials, electronic circuit board etching equipment, light curing resin, optical recording materials, polyolefin additives, polyvinyl chloride stabilizers, plasticizers, flame retardants, epoxy resin, surfactants, lubricating oil additives, propylene glycol, and hydrogen peroxide. The Food Products segment deals with margarine, shortenings, and fillings. The Life Science segment includes agricultural chemicals, pharmaceuticals, quasi-drugs, veterinary drugs, wood chemicals, and medical materials. The Others segment includes construction management, logistics services, and real estate businesses. The company was founded on January 27, 1917 and is headquartered in Tokyo, Japan.